Cresco Labs CEO on why 2021 can even be a breakout 300 and sixty five days for the marijuana industry
Charlie Bachtell, Cresco Labs CEO, joins CNBC’s “Mercurial Money” to discuss surging pot stocks as marijuana advocates await passage of a federal decriminalization invoice. For get entry to to are…
Cresco Labs buys Columbia Care in $2 billion marijuana merger
Charlie Bachtell, Cresco Labs CEO, joins CNBC’s “Posthaste Cash” to keep in touch about his company’s $2 billion deal to make your mind up on Columbia Care. For get right…